The Alliance for Aging Research has launched a new campaign, Making $ense of Arthritis, to help senior citizens discuss cost-effective treatments with their physicians. Most of those surveyed said they would be willing to talk with their physician about the cost of different osteoarthritis medications if they had the information to initiate a discussion. The rate of multiple births was 0.59 percent among women who took any folic acid supplement and 0.65 percent among women who did not take any such supplements.Ĭan we lessen the financial “ouch” of osteoarthritis treatment? Of 1,000 adults surveyed by Harris Interactive for the Alliance for Aging Research, 86 percent said they would be concerned about the cost of managing osteoarthritis and 68 percent said that choosing a cost-effective treatment would be difficult without a physician's guidance. More than 99 percent of the women had single births. The records of 242,015 women enrolled in a population-based cohort study in China were assessed for folic acid intake before or during early pregnancy and the occurrence of multiple births among them.
Companies are committing their financial resources to the marketing of existing products rather than the development of new ones.įolic acid supplements taken during pregnancy are not linked to multiple births, according to results of a study published in The Lancet. The reason? Not surprisingly, financial considerations are said to influence the development of drugs. Food and Drug Administration approved only 15 new drugs last year, compared with an annual average of 31 over the previous five years. The world needs more new drugs, according to an editorial published in Nature Reviews Drug Discovery and reported in BMJ. Higher scores were associated with increasing age, residence in a two-parent household, and higher levels of maternal education. Verbal and full-scale IQ scores showed similar increases. On average, their scores on a picture vocabulary test jumped about 10 points between the ages of 36 and 96 months, compared with normative data indicating a 4.5-point jump in median scores in children tested over time. Follow-up data were obtained on 296 infants born weighing 600 to 1,250 g (1 lb, 5 oz to 2 lb, 12 oz) and evaluated at 36, 54, 72, and 96 months of corrected age. The developing brain may be more resilient than previously was thought, shows a prospective, randomized, placebo-controlled study published in JAMA.
0 kommentar(er)
